Vitamin K2 1% (MK-7)
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
9 mg
Serving Size
2778
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
90 mcg
(75% DV)
✅ Within RDA (0.8× RDA of 0.12 mg)
📚 273 studies (Tier A: 9, B: 175)
Other Ingredients
Dicalcium Phosphate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Product Information
📋 Directions for Use
Suggested Use: As a dietary supplement, take 9 mg once daily with food, or as directed by a physician.
⚠️ Warnings & Precautions
Always consult a physician before taking any dietary supplement.
Keep out of reach of children.
🧪 Formulation Notes
Free of: Soy, dairy, yeast, gluten, added sugars
Additional Information
Use an accurate milligram scale to measure.
Contents are sold by weight, not volume. Settling may occur. Store in a dry, cool, dark place.
New
Product Details
UPC / SKU
X002KU029N
DSLD Entry Date
2024-04-23
Product Type
Vitamin
Form
Powder
Brand
BulkSupplements.com
DSLD ID
311794
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin K1 1%
BulkSupplements.com
100
Vitamin K1 1%
BulkSupplements.com
100
Vitamin K1 1%
BulkSupplements.com
100
Vitamin K1 1%
BulkSupplements.com
100
Vitamin K1 1%
BulkSupplements.com
100